Kim Annink

190 Chapter 8 24 . Boda D, Nemeth I, Hencz P, Denes K. Effect of allopurinol treatment in premature infants with idiopathic respiratory distress syndrome. Developmental pharmacology and therapeutics. 1984;7(6):357-67. 25 . Ramasamy SN, Korb-Wells CS, Kannangara DR, Smith MW, Wang N, Roberts DM, et al. Allopurinol hypersensitivity: a systematic review of all published cases, 1950- 2012. Drug safety. 2013;36(10):953-80. 26 . Stamp LK, Day RO, Yun J. Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Nature reviews Rheumatology. 2016;12(4):235-42. 27 . Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. The New England journal of medicine. 2005;353(15):1574-84. 28 . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191-4. 29 . Kaandorp JJ, van den Broek MP, Benders MJ, Oudijk MA, Porath MM, Bambang Oetomo S, et al. Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labour. Archives of disease in childhood Fetal and neonatal edition. 2014;99(2):F144-8. 30 . Tavakkoli F. Review of the role of mannitol in the therapy of children. 18th Expert Committee on the selection and use of Essential Medicines Mannitol review (Children). 2011;16. 31 . Cadence Pharmaceuticals, Inc. - OFIRMEV® (acetaminophen) injection - Approval Label (PDF) 11/2010 - https://www.accessdata.fda.gov/drugsatfda_docs/ label/2010/022450lbl.pdf (downloaded 2019/01/29). 32 . Fresenius Kabi USA, LLC - Acetaminophen Injection, for intravenous use - Approval Label (PDF) 10/2015 - https://www.accessdata.fda.gov/drugsatfda_docs/ label/2015/204767s000lbl.pdf (downloaded 2019/01/29) 33 . Mallinckrodt Hospital Products Inc. - OFIRMEV® (acetaminophen) injection - Labeling-Package Insert (PDF) 04/2018 - https://www.accessdata.fda.gov/ drugsatfda_docs/label/2018/022450s011lbl.pdf (downloaded 2019/01/29).

RkJQdWJsaXNoZXIy ODAyMDc0